ANAB - ANAPTYSBIO, INC
IEX Last Trade
14.345
0.150 1.046%
Share volume: 27,459
Last Updated: Mon 13 Jan 2025 08:30:08 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$14.20
0.15
1.06%
View ratios
Fiscal Date | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
Report Date | 2024-05-09 | 2023-08-07 | 2023-11-02 | 2024-11-05 | 2024-05-09 | 2024-08-05 | 2024-11-05 | |
Total revenue | 1.374 M | 3.460 M | 3.318 M | 9.005 M | 7.179 M | 10.971 M | 30.017 M | |
Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Gross profit | 1.374 M | 3.460 M | 3.318 M | 9.005 M | 7.179 M | 10.971 M | 30.017 M | |
151.82% | -4.10% | 171.40% | -20.28% | 52.82% | 173.60% | |||
Operating expenses | 45.775 M | 43.603 M | 41.050 M | 51.140 M | 49.380 M | 51.292 M | 52.774 M | |
Selling general and admin | 10.818 M | 10.680 M | 10.172 M | 10.276 M | 12.338 M | 9.295 M | 10.562 M | |
Research and development | 34.957 M | 32.923 M | 30.878 M | 40.864 M | 37.042 M | 41.997 M | 42.212 M | |
Total expenses | 45.775 M | 43.603 M | 41.050 M | 51.140 M | 49.380 M | 51.292 M | 52.774 M | |
-4.74% | -5.86% | 24.58% | -3.44% | 3.87% | 2.89% | |||
Operating income | -44.401 M | -40.143 M | -37.732 M | -42.135 M | -42.201 M | -40.321 M | -22.757 M | |
Ebit | -44.405 M | -40.140 M | -37.731 M | -42.137 M | -42.203 M | -40.321 M | -22.762 M | |
Pretax income | -44.255 M | -39.845 M | -37.308 M | -42.215 M | -43.936 M | -46.651 M | -32.851 M | |
-9.96% | -6.37% | 13.15% | 4.08% | 6.18% | -29.58% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 9.000 K | 0.000 | |
Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income | -44.255 M | -39.845 M | -37.308 M | -42.211 M | -43.936 M | -46.660 M | -32.851 M | |
9.96% | 6.37% | -13.14% | -4.09% | -6.20% | 29.59% |